FADS1 and neoplasm: In addition, concurrent treatment with dihomo-γ-linolenic acid along with 5-FU in mice bearing delta-5-desaturase-KD tumors led to an improved tumor size reduction (100.1 ± 24.3 mm3, Fig. 4b).